Cochrane Review Group
Metabolic and Endocrine Disorders
84 systematic reviews in Metabolic and Endocrine Disorders ask 1,105 questions. 39.3% have no studies to answer them, 22.3% rest on very low certainty evidence and 14.1% reach moderate or high certainty.
Reviews
84
Questions
1,105
current versions
No studies
39.3%
Moderate or high
14.1%
No studies 434 · 39.3%Ungraded 32 · 2.9%Very low 246 · 22.3%Low 237 · 21.4%Moderate 132 · 11.9%High 24 · 2.2%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Health‐related quality of life · participants living with overweight or obesity Calcium supplementation for people with overweight or obesity (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · participants living with overweight or obesity Calcium supplementation for people with overweight or obesity (2024) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Morbidity · participants living with overweight or obesity Calcium supplementation for people with overweight or obesity (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Sexual quality of life · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Treatment withdrawal due to adverse events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | RR 1.04 [0.58, 1.86] | 2 studies · 122 participants | Very low |
Testosterone vs placebo Prostate‐related events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs placebo Lower urinary tract symptoms · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs PDE5I Erectile function · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | 1 study · 64 participants | Very low |
Testosterone vs PDE5I Sexual quality of life · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | 1 study · 64 participants | Very low |
Testosterone vs PDE5I Cardiovascular mortality · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Testosterone vs PDE5I Treatment withdrawal due to adverse events · men with sexual dysfunction Testosterone replacement in men with sexual dysfunction (2024) · Cochrane | no estimate extracted | NR | No studies |
Reviews 84
Thyroid surgery for Graves’ disease and Graves’ ophthalmopathy
CochraneSoF table
21 questions
Aromatase inhibitors for short stature in male children and adolescents
CochraneSoF table
7 questions
Parent‐only interventions for childhood overweight or obesity in children aged 5 to 11 years
CochraneSoF table
28 questions
Surgery for weight loss in adults
CochraneSoF table
42 questions
Levothyroxine or minimally invasive therapies for benign thyroid nodules
CochraneSoF table
28 questions
Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus
CochraneSoF table
7 questions
Vitamin D supplementation for prevention of cancer in adults
CochraneSoF table
7 questions
Vitamin D supplementation for prevention of mortality in adults
CochraneSoF table
7 questions
Transtheoretical model stages of change for dietary and physical exercise modification in weight loss management for overweight and obese adults
CochraneSoF table
6 questions
Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus
CochraneSoF table
16 questions
Reminder systems for women with previous gestational diabetes mellitus to increase uptake of testing for type 2 diabetes or impaired glucose tolerance
CochraneSoF table
6 questions
Chinese herbal medicines for benign thyroid nodules in adults
CochraneSoF table
7 questions
Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus
CochraneSoF table
7 questions
Hormone replacement therapy for women with type 1 diabetes mellitus
CochraneSoF table
6 questions
Computer‐based diabetes self‐management interventions for adults with type 2 diabetes mellitus
CochraneSoF table
6 questions
Sulphonylurea monotherapy for patients with type 2 diabetes mellitus
CochraneSoF table
21 questions
Sweet potato for type 2 diabetes mellitus
CochraneSoF table
7 questions
Isoflavones for hypercholesterolaemia in adults
CochraneSoF table
6 questions
Chinese herbal medicines for hypertriglyceridaemia
CochraneSoF table
6 questions
Chromium picolinate supplementation for overweight or obese adults
CochraneSoF table
6 questions
Selenium supplementation for Hashimoto's thyroiditis
CochraneSoF table
6 questions
Self‐monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin
CochraneSoF table
7 questions
Adenosine‐diphosphate (ADP) receptor antagonists for the prevention of cardiovascular disease in type 2 diabetes mellitus
CochraneSoF table
7 questions
Cinnamon for diabetes mellitus
CochraneSoF table
6 questions
Interactive computer‐based interventions for weight loss or weight maintenance in overweight or obese people
CochraneSoF table
12 questions